Why diagnose Parkinson's disease at the 'preclinical' phase

被引:0
|
作者
Wolters, E. Ch. [1 ]
机构
[1] VUMC, Dept Neurol, Amsterdam, Netherlands
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:337 / 337
页数:1
相关论文
共 50 条
  • [1] Are clinical tools able to diagnose Parkinson's disease at the 'preclinical phase'?
    Deste, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 336 - 337
  • [2] Preclinical (premotor) Parkinson’s disease
    E. Ch. Wolters
    C. Francot
    P. Bergmans
    A. Winogrodzka
    J. Booij
    H. W. Berendse
    J. C. Stoof
    Journal of Neurology, 2000, 247 (Suppl 2) : 103 - 109
  • [3] Preclinical diagnosis of Parkinson's disease
    Oertel, W. H.
    Eggert, K. M.
    Moeller, C. J.
    Mayer, T. J. J. Geert
    Behlke, M.
    Knake, S.
    Unger, M. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 7 - 7
  • [4] Preclinical (premotor) Parkinson's disease
    Wolters, EC
    Francot, C
    Bergmans, P
    Winogrodzka, A
    Booij, J
    Berendse, HW
    Stoof, JC
    JOURNAL OF NEUROLOGY, 2000, 247 : 103 - 109
  • [5] The Challenge and Opportunity to Diagnose Parkinson's Disease in Midlife
    Kilzheimer, Alexander
    Hentrich, Thomas
    Burkhardt, Simone
    Schulze-Hentrich, Julia M.
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [6] Neurotoxins as Preclinical Models for Parkinson's Disease
    Segura-Aguilar, Juan
    NEUROTOXICITY RESEARCH, 2018, 34 (04) : 870 - 877
  • [7] Neurotoxins as Preclinical Models for Parkinson’s Disease
    Juan Segura-Aguilar
    Neurotoxicity Research, 2018, 34 : 870 - 877
  • [8] Pathogenesis and preclinical course of Parkinson's disease
    Foley, P
    Riederer, P
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1999, (56): : 31 - 74
  • [9] Constipation - A preclinical marker of Parkinson's disease
    Rana, M. A.
    Rana, A. Q.
    Mujawaz, Y.
    MOVEMENT DISORDERS, 2013, 28 : S308 - S309
  • [10] Aminochrome as preclinical model for Parkinson's disease
    Segura-Aguilar, Juan
    ONCOTARGET, 2017, 8 (28) : 45036 - 45037